Medicine

The Impact of a Biopsy Based 17‐Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance

K. Badani, Michael J. Kemeter, P. Febbo, Jeffrey H. Lawrence, B. Dénes, M. Rothney, M. Rothberg, G. Brown

2015.7.1Urology Practice

DOI: 10.1016/j.urpr.2014.10.010

tlooto Summary

This study demonstrates that the 17‐gene GPS influenced treatment recommendations among urologists and provided increased confidence in these recommendations in patients at NCCN very low to low‐intermediate risk.

Abstract

Abstract is not available.

Citation format

BADANI, K., et al. The impact of a biopsy based 17‐gene genomic prostate score on treatment recommendations in men with newly diagnosed clinically prostate cancer who are candidates for active surveillance. Urology Practice, 2015, 2: 181–189.